Company / Operating Cash Flow
INSMED Inc Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$935.0M
FY2025
5-year range
-$935.0M / -$363.3M
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
#215 of 216
Health Care
What the data says
Among 216 Health Care companies, INSMED Inc is in the bottom 0% for operating cash flow. Operating Cash Flow has declined for 5 consecutive years, from -$219M in FY2020 to -$935M in FY2025.
Based on SEC 10-K filings.
-$935M in FY2025.
Declined from -$536M to -$935M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 216This company -$935.0M Sector average $658.7M
▼
-241.9% below sector average
Key checks
Key Insights
- INSMED Inc's operating cash flow has declined for 5 consecutive years.
- In FY2025, operating cash flow decreased 36.7% year-over-year.
- Ranks #215 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$935.0M | -36.7% |
| FY2024 | -$683.9M | -27.5% |
| FY2023 | -$536.2M | -33.9% |
| FY2022 | -$400.4M | -10.2% |
| FY2021 | -$363.3M | -65.6% |
| FY2020 | -$219.3M | +12.5% |
| FY2019 | -$250.6M | +2.8% |
| FY2018 | -$258.0M | -61.6% |
| FY2017 | -$159.6M | -8.8% |
| FY2016 | -$146.7M | -45.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026